SubsidieMeestersInnovative multifunctional and smart coatings to prevent medical device related infections
SPARTHA Medical develops multifunctional antimicrobial coatings and eco-friendly sprays to prevent infections in surgical implants and offers customized solutions for various industries.
Projectdetails
Introduction
Infections represent one of the major risks of surgery implants and the main cause of implant rejection, affecting over 5% of patients who undergo implant surgery (around 2M patients in the EU).
Company Background
At SPARTHA Medical, created in 2019 as a spin-off of INSERM Biomaterials Unit (Strasbourg), we developed a multifunctional coating with antimicrobial and anti-inflammatory properties to prevent infections in implants and surgical care.
Product Development
In addition to this medical coating to be used directly in hospitals, we developed a second product:
- A biocompatible, eco-friendly spray with antibacterial & antiviral properties for general and daily use.
We also offer a customized coating development service for medical device manufacturers, which leads to recurring licensing.
Versatility and Expansion
Our coating platform is so versatile that the applications are endless. We are also integrating the development service to electronics and cosmetics companies.
Current Status
We have signed 7 contract agreements so far, and 2 more are in advanced negotiations.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.389.625 |
| Totale projectbegroting | € 3.413.750 |
Tijdlijn
| Startdatum | 1-8-2022 |
| Einddatum | 31-7-2025 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- SPARTHA MEDICALpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
SAFE-ON Technology for Smart Antimicrobial CoatingsThis project aims to optimize and commercialize the SAFE-ON antimicrobial coating technology through prototype development and market analysis to combat infectious diseases. | ERC POC | € 150.000 | 2022 | Details |
New generation of bioactive coating for intravenous catheters and implantable medical devices to prevent infections and thrombosisDeveloping a novel coating technology using layer-by-layer cross-linked nanogels to prevent thrombosis and bloodstream infections in implantable medical devices, aiming for market readiness. | EIC Transition | € 2.476.343 | 2024 | Details |
LipoCoat voor urologie katheters: Terugdringen van urineweg infectiesDit project richt zich op het uitvoeren van een markthaalbaarheidsstudie voor een innovatieve coating op urologiekatheters om infecties te verminderen en kosten te verlagen. | MIT Haalbaarheid | € 20.000 | 2023 | Details |
Antimicrobiële coating voor orthopedische trauma materialenZorgZorg Innovaties Nederland ontwikkelt een antimicrobiële Bioprex-coating voor orthopedische trauma materialen om ziekenhuisinfecties te verminderen en de marktpotentie te vergroten. | MIT Haalbaarheid | € 19.968 | 2022 | Details |
SAFE-ON Technology for Smart Antimicrobial Coatings
This project aims to optimize and commercialize the SAFE-ON antimicrobial coating technology through prototype development and market analysis to combat infectious diseases.
New generation of bioactive coating for intravenous catheters and implantable medical devices to prevent infections and thrombosis
Developing a novel coating technology using layer-by-layer cross-linked nanogels to prevent thrombosis and bloodstream infections in implantable medical devices, aiming for market readiness.
LipoCoat voor urologie katheters: Terugdringen van urineweg infecties
Dit project richt zich op het uitvoeren van een markthaalbaarheidsstudie voor een innovatieve coating op urologiekatheters om infecties te verminderen en kosten te verlagen.
Antimicrobiële coating voor orthopedische trauma materialen
ZorgZorg Innovaties Nederland ontwikkelt een antimicrobiële Bioprex-coating voor orthopedische trauma materialen om ziekenhuisinfecties te verminderen en de marktpotentie te vergroten.